#lean body mass

Discover 3 curated intelligence briefings related to this specific topic.

The Sarcopenia Shadow: Ozempic's Lean Mass Tax
Science & Health

The Sarcopenia Shadow: Ozempic's Lean Mass Tax

The weight is vanishing, but the machinery is failing. An intel report on the unseen secondary effect of GLP-1 agonists: the systemic liquidation of skeletal muscle.

Read Analysis
The Cellular Purge: How Senolytic Breakthroughs are Rewriting the Biological Clock
Health & Medicine

The Cellular Purge: How Senolytic Breakthroughs are Rewriting the Biological Clock

New breakthroughs in senolytic therapy are shifting from broad-spectrum clearance to organ-specific precision, offering a tangible path toward reversing biological age in the heart, kidneys, and lungs.

Read Analysis
The Muscle Preservation Protocol: Safeguarding Lean Mass in the Era of GLP-1s
Health & Medicine

The Muscle Preservation Protocol: Safeguarding Lean Mass in the Era of GLP-1s

Rapid weight loss via GLP-1 agonists often hides a dangerous secret: significant lean muscle loss. This guide provides a clinical-grade protocol to preserve metabolic health, maintain strength, and ensure weight loss comes from fat, not functional tissue.

Read Analysis